- Home
- EXOZ vs ZTEK Comparison
EXOZ vs ZTEK Comparison
Compare EXOZ & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXOZ
- ZTEK
- Stock Information
- Founded
- EXOZ 2014
- ZTEK 2008
- Country
- EXOZ United States
- ZTEK Canada
- Employees
- EXOZ N/A
- ZTEK N/A
- Industry
- EXOZ
- ZTEK Major Chemicals
- Sector
- EXOZ
- ZTEK Industrials
- Exchange
- EXOZ NYSE
- ZTEK Nasdaq
- Market Cap
- EXOZ 89.8M
- ZTEK 103.3M
- IPO Year
- EXOZ N/A
- ZTEK N/A
- Fundamental
- Price
- EXOZ $14.55
- ZTEK $1.53
- Analyst Decision
- EXOZ
- ZTEK
- Analyst Count
- EXOZ 0
- ZTEK 0
- Target Price
- EXOZ N/A
- ZTEK N/A
- AVG Volume (30 Days)
- EXOZ 13.7K
- ZTEK 84.7K
- Earning Date
- EXOZ 05-12-2025
- ZTEK 06-26-2025
- Dividend Yield
- EXOZ N/A
- ZTEK N/A
- EPS Growth
- EXOZ N/A
- ZTEK N/A
- EPS
- EXOZ N/A
- ZTEK N/A
- Revenue
- EXOZ N/A
- ZTEK $44,936.00
- Revenue This Year
- EXOZ N/A
- ZTEK N/A
- Revenue Next Year
- EXOZ N/A
- ZTEK N/A
- P/E Ratio
- EXOZ N/A
- ZTEK N/A
- Revenue Growth
- EXOZ N/A
- ZTEK 92.38
- 52 Week Low
- EXOZ $8.50
- ZTEK $0.50
- 52 Week High
- EXOZ $23.99
- ZTEK $1.31
- Technical
- Relative Strength Index (RSI)
- EXOZ N/A
- ZTEK 56.43
- Support Level
- EXOZ N/A
- ZTEK $1.51
- Resistance Level
- EXOZ N/A
- ZTEK $1.74
- Average True Range (ATR)
- EXOZ 0.00
- ZTEK 0.19
- MACD
- EXOZ 0.00
- ZTEK -0.01
- Stochastic Oscillator
- EXOZ 0.00
- ZTEK 56.94
About EXOZ EXOZYMES INC
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.